Somewhere in your organization, the answer to next quarter's hardest question already exists. It sits in a contract clause nobody indexed, a support ticket thread nobody summarized, a call transcript ...

Explore the latest news and expert commentary on Vulnerabilities & Threats, brought to you by the editors of Dark Reading ...

A new AAV-based gene therapy successfully improved seizures, behavior, and brain activity in fragile X syndrome mice, paving the way for clinical development.